The polymorphism of the ATP-binding cassette transporter 1 gene modulates alzheimer disease risk in chinese han ethnic population

American Journal of Geriatric Psychiatry

Volumn 20, Issue 7, 2012, Pages 603-611

  Sun, Yi Min ^a   Li, Hong Lei ^a   Guo, Qi Hao ^a   Wu, Ping ^a   Hong, Zhen ^a   Lu, Chuan Zhen ^a   Wu, Zhi Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Alzheimer disease; ATP binding cassette transporter 1; polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CHROMOSOME 9Q; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863510673     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3182423b6a     Document Type: Article

References (37)

1. Sando SB, Melquist S, Cannon A, et al: APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol 2008; 8:9
2. Bertram L, Tanzi RE, et al: Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008; 9(10):768-778
3. Vitiello G, Grimaldi M, Ramunno A, et al: Interaction of a betasheet breaker peptide with lipid membranes. J Pept Sci 2010; 16(2):115-122
4. Colell A, Ferńandez A, Ferńandez-Checa JC: Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J Bioenerg Biomembr 2009; 41(5):417-423
5. Takechi R, Galloway S, Pallebage-Gamarallage MM, et al: Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk. Prog Lipid Res 2010; 49(2):159-170
6. Sparks DL: Cholesterol metabolism and brain amyloidosis: evidence for a role of copper in the clearance of Abeta through the liver. Curr Alzheimer Res 2007; 4(2):165-169 (Pubitemid 46557506)
7. McLaurin J, Darabie AA, Morrison MR: Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis. Pharmacopsychiatry 2003; 36(Suppl 2):130-135
8. Martins IJ, Berger T, Sharman MJ, et al: Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 2009; 111(6):1275-1308
9. Abisambra JF, Fiorelli T, Padmanabhan J, et al: LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease. PLoS One 2010; 5(1):e8556
10. Sabbagh MN, Thind K, Sparks DL: On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks. Alzheimer Dis Assoc Disord 2009; 23(4): 303-305
11. Fonseca AC, Resende R, Oliveira CR, et al: Cholesterol and statins in Alzheimer's disease: current controversies. Exp Neurol 2010; 223(2):282-293
12. Kirsch C, Eckert GP, Mueller WE: Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 2003; 65(5):843-856 (Pubitemid 36293701)
13. Oram JF, Lawn RM: ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 2001; 42(8):1173-1179 (Pubitemid 32744239)
14. Blacker D, Bertram L, Saunders AJ, et al: Results of a highresolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12(1):23-32 (Pubitemid 36097712)
15. Pericak-Vance MA, Grubber J, Bailey LR, et al: Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000; 35(9-10):1343-1352
16. Fan J, Donkin J,Wellington C: Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors 2009; 35(3):239-248
17. Hirsch-Reinshagen V, Burgess BL, Wellington CL: Why lipids are important for Alzheimer disease? Mol Cell Biochem 2009; 326(1-2):121-129
18. Wahrle SE, Jiang H, Parsadanian M, et al: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 2004; 279(39):40987-40993 (Pubitemid 39287699)
19. Li Y, Tacey K, Doil L, et al: Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 2004; 366(3):268-271 (Pubitemid 39024279)
20. Wang F, Jia J: Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res 2007; 1147:34-38 (Pubitemid 46574561)
21. Slatter TL, Jones GT, Williams MJ, et al: Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. Clin Genet 2008; 73(2):179-184
22. Tan JH, Low PS, Tan YS, et al: ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 2003; 113(2):106-117 (Pubitemid 36869023)
23. Wang N, Xue XH, Lin Y, et al: The R219K polymorphism in the ATP-binding cassette transporter 1 gene has a protective effect on atherothrombotic cerebral infarction in Chinese Han ethnic population. Neurobiol Aging 2010; 31(4):647-653
24. Donohoe GG, Salom̈aki A, Lehtim̈aki T, et al: Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 1999; 45(1):143-146 (Pubitemid 29036403)
25. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, et al: Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004; 114(9):1343-1353 (Pubitemid 40385306)
26. Katzov H, Chalmers K, Palmgren J, et al: Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 2004; 23(4): 358-367 (Pubitemid 38461517)
27. Clee SM, Zwinderman AH, Engert JC, et al: Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103(9):1198-1205 (Pubitemid 32221340)
28. Brousseau ME, Bodzioch M, Schaefer EJ, et al: Common variants in the gene encoding ATP-binding cassette transporter 1 in men with lowHDL cholesterol levels and coronary heart disease. Atherosclerosis 2001; 154(3):607-611 (Pubitemid 32232157)
29. Kyriakou T, Pontefract DE, Viturro E, et al: Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet 2007; 16(12):1412-1422 (Pubitemid 47061338)
30. Evans D, Beil FU: The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidemia. J Mol Med 2003; 81(4):264-270 (Pubitemid 36578925)
31. Rodŕguez-Rodŕguez E, Mateo I, Llorca J, et al: Association of genetic variants of ABCA1 with Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(7):964-968 (Pubitemid 47548001)
32. Sundar PD, Feingold E, Minster RL, et al: Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging 2007; 28(6):856-862 (Pubitemid 46589738)
33. K̈olsch H, L̈utjohann D, Jessen F, et al: Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. Int J Mol Med 2006; 17(5):791-794
34. Wahrle SE, Shah AR, Fagan AM, et al: Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol Neurodegener 2007; 2:7
35. Shibata N, Kawarai T, Lee JH, et al: Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 2006; 391(3):142-146 (Pubitemid 41736188)
36. Wollmer MA, Streffer JR, L̈utjohann D, et al: ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 2004; 24(3):421-426 (Pubitemid 36205049)
37. Huang W, Qiu C, von Strauss E, et al: APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year followup study. Arch Neurol 2004; 61(12):1930-1934 (Pubitemid 39612954)